Role of Aquaporin1 in Permeability of Schlemm's Canal
About the Research Project
Program
Award Type
Standard
Award Amount
$69,974
Active Dates
April 01, 2001 - March 31, 2003
Grant ID
G2001026
Summary
Aquaporin-1 is a protein “water shunt” that enables the rapid movement of water in many parts of the body. For example, “water shunts” are responsible for the rapid formation of saliva in the mouth. Dr. Stamer has hypothesized that fluid has difficulty getting out of the eye in part because of the dysfunction or decreased expression of a protein called Aquaporin-1. He has developed techniques to specifically isolate and grow cells from the trabecular meshwork and Schlemm’s Canal of human eyes. This is allowing him to study how fluid moves across these cells in the laboratory. He is also examining the contribution of Aquaporin-1 to fluid movement in an intact outflow system from donated human eyes. It is hoped that these experiments will provide scientists with valuable information about the role of Aquaporin-1 in the removal of fluid from the eye and may lead to new therapies for the treatment of glaucoma.
Grantee institution at the time of this grant: University of Arizona
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute